You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Plasmonic Nanosensors for Chemical Warfare Agents

    SBC: MKS Technology            Topic: A11019

    This project will develop an integrated nanoplasmonic sensor Raman device to detect chemical warfare agents. The Raman device will be designed and produced by MKS Technology and will be cell-phone sized for portability. The device will: operate from 2-AA batteries; have a touch screen user-interface; will have Bluetooth connectivity, and will be ruggedized to MIL-STD-810G. The reader will have ...

    SBIR Phase II 2013 Department of DefenseArmy
  2. Highly-Scalable Computational-Based Engineering Algorithms for Emerging Parallel Machine Architectures

    SBC: SCIENTIFIC SIMULATIONS, LLC            Topic: AF10BT13

    ABSTRACT: In order to significantly advance the fidelity and capability of current computational engineering tools, algorithms, techniques, and software which map effectively to emerging massively parallel hardware architectures must be developed. The objective of this project is to investigate and demonstrate specific techniques for enhancing the scalability of computational fluid dynamics (CFD) ...

    STTR Phase II 2013 Department of DefenseAir Force
  3. A Novel Adherence Technology for Ophthalmic Medications

    SBC: Glycobac, LLC            Topic: NIGMS

    DESCRIPTION: Most human therapeutic glycoproteins (biologics) are manufactured using mammalian cell lines that can add the human-type glycans required for their clinical efficacy. However, mammalian cells have some serious disadvantages - it takes a longtime to establish production lines, they can contain adventitious agents, and they can produce immunogenic glycans. The baculovirus-insect cell s ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government